CandleAI Lab hub
Focused lab hub · research-use only

Tools catalog

Honest availability on one DGX Spark — not a 250-model marketplace. Live runs today. Next / Roadmap follow a fixed ship order (cash path → ESMFold → DiffDock → one complex engine). Free taste is structure only — design and docking stay paid/managed.

Loading queue status…

Live now

Live PREDICT

ColabFold / AF2 structure

FASTA → MSA → structure → pLDDT/PAE → QC-A path. Primary engine for free + Paid Pilot.

  • Engine: colabfold-af2
  • Free self-serve: 1 sequence ≤400 aa
  • Paid Pilot: ≤3 × ≤400 aa · $750
Queue Single GPU

Spark job queue

One active heavy fold at a time. We pause competing GPU work during pilot folds.

  • Fair-use free limits
  • Status poll: /api/job/{id}
  • MSA default: public API (local MSA expanding)

Ship next (fixed order)

Next · P1 PREDICT

ESMFold

Fast single-sequence folds — second PREDICT mode for orphans / snappy taste. Not Live until Spark smoke + QC.

  • SKU: CA-PROTEIN-PREDICT (engine=esmfold)
  • Free path will share ≤400 limit once Live
Next · P1 Upsell

DiffDock

Ligand pose hypotheses on a receptor we already folded. Paid add-on after structure — not free bait.

  • SKU: CA-PROTEIN-DIFFDOCK
  • Chain: AF2/ESMFold PDB → poses

Complexes & design

Roadmap · P2 COMPLEX

OpenFold-3 (primary pick)

Open AF3-class complexes after cash path is real. Board: Live at most one complex engine.

Eval · P2

Boltz-2

Parallel eval for multi-component + affinity-style scores. Lives only if it wins go/no-go vs OpenFold-3 — not both.

On demand · P3 DESIGN

ProteinMPNN

Inverse folding / sequence design when labs ask for design — paid DESIGN, never free attract.

Parked

Chai-1

Parked so we do not run three complex stacks. Install only if a pilot requires Chai by name.

Ship order and owners: staff Roadmap board (login). Spec: docs/specs/candleai-engine-roadmap-execution-p0.md.

Computational research tool only. Not a medical device. Outputs are predictions for research use; the customer is solely responsible for wet-lab validation, regulatory strategy, and clinical decisions.